CRAC intermediate 2
CRAC intermediate 2 (the starting compound in example 23) is an intermediate. CRAC intermediate 2 can be used in the research of CRAC inhibitors[1].
Product Specifications
CAS Number
[123066-64-8]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CRAC Channel; Drug Intermediate
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/CRAC-intermediate-2.html
Purity
99.45
Solubility
DMSO : ≥ 52 mg/mL
Smiles
NC1=CC=C(N2N=C(C(F)(F)F)C=C2C(F)(F)F)C=C1
Molecular Formula
C11H7F6N3
Molecular Weight
295.18
Precautions
H302, H315, H319, H335
References & Citations
[1]Cao, et al. Compounds that modulate intracellular calcium. WO2013059666A1. WIPO (PCT) . 2012-10-19.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
129404-FITC 100 µL
MAPK3 (Mitogen-activated Protein Kinase 3, MAPK 3, MAP Kinase 3, ERT2, Extracellular Signal-regulated Kinase 1, ERK1, ERK-1, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, Microtubule-associated Protein 2 Kinase, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, P44ERK1, p44-ERK1, P44MAPK, p44-MAPK, PRKM3, MGC20180) (FITC)
Ask
View Details 
